首页> 外国专利> Improvements in or relating to the production of substances which reduce the bleeding time of animals

Improvements in or relating to the production of substances which reduce the bleeding time of animals

机译:改善动物生产或减少动物出血时间的物质生产方面的改进

摘要

A preparation which reduces the bleeding time of animals is obtained by forming an aqueous extract from spleen material or soya bean flour, precipitating the enzymes therefrom, incubating the enzymes with an ascorbic acid substance having vitamin C activity, and recovering the product from the solution. The product is designated Splenin A and has the empirical formula C18H40O5 or C18H36O5. The precipitation of the enzymes from the aqueous extract may be effected by the addition of acetone or alcohol. The precipitate may then be added to a solution of l-ascorbic acid in a phosphate or borate buffer solution at pH 8, the mixture being incubated at 37-38 DEG C. for about 20 days. The incubated material is then extracted with ether or chloroform at a temperature not greater than 50 DEG C., the aqueous residue being subjected to further incubation and the non-aqueous phase being shaken twice with aqueous 2.5 per cent sodium bicarbonate. The non-aqueous phase is then shaken with 0.5 N-sodium bicarbonate, the aqueous phase now containing the Splenin A being acidified to pH 4.7 by sulphuric acid. The acid solution is extracted with chloroform, and the extract is dried by means of anhydrous sodium sulphate and is then evaporated to dryness. The residue is taken up with heavy petroleum ether, the solution is shaken with methanol, and the petroleum ether solution is evaporated to dryness. The residue is re-dissolved in boiling acetone and the acetone is allowed to come to room temperature, whereupon the Splenin A is precipitated. The incubation step is activated by the presence of small quantities of cysteine or sodium cyanide and in this step dehydroascorbic acid, diketogluconic and or the sodium, calcium, or other salts of ascorbic acid may be used instead of l-ascorbic acid. The chloroform purification step prior to the bicarbonate treatment referred to above may be replaced by adsorption of the Splenin A on charcoal followed by treatment with hot methanol to recover the material.ALSO:A preparation which reduces the bleeding time of animals is obtained by forming an aqueous extract from spleen material or soya bean flour, precipitating the enzymes therefrom, incubating the enzymes with an ascorbic acid substance having vitamin C activity, and recovering the product from the solution. The product is designated Splenin A and has the empirical formula C18H40O5 or C18H36O5. The precipitation of the enzymes from the aqueous extract may be effected by the addition of acetone or alcohol. The precipitate may then be added to a solution of l-ascorbic acid in a phosphate or borate buffer solution at pH 8, the mixture being incubated at 37-38 DEG C for about 20 days. The incubated material is then extracted with ether or chloroform at a temperature not greater than 50 DEG C, the aqueous residue being subjected to further incubation and the non-aqueous phase being shaken twice with aqueous 2.5 per cent sodium bicarbonate. The non-aqueous phase is then shaken with 0.5 N sodium bicarbonate, the aqueous phase now containing the Splenin A being acidified to pH 4.7 by sulphuric acid. The acid solution is extracted with chloroform, and the extract is dried by means of anhydrous sodium sulphate and is then evaporated to dryness. The residue is taken up with heavy petroleum ether, the solution is shaken with methanol, and the petroleum ether solution is evaporated to dryness. The residue is re-dissolved in boiling acetone and the acetone is allowed to come to room temperature, whereupon the Splenin A is precipitated. The incubation step is activated by the presence of small quantities of cysteine or sodium cyanide and in this step dehydroascorbic acid, diketogluconic and or the sodium, calcium, or other salts of ascorbic acid may be used instead of l-ascorbic acid. The chloroform purification step prior to the bicarbonate treatment referred to above may be replaced by adsorption of the Splenin A on charcoal followed by treatment with hot methanol to recover the material.
机译:通过从脾脏原料或大豆粉中形成水提取物,从其中沉淀酶,将酶与具有维生素C活性的抗坏血酸物质一起温育,并从溶液中回收产物,可以获得减少动物出血时间的制剂。该产品命名为Splenin A,其经验式为C18H40O5或C18H36O5。酶从水提取物中的沉淀可以通过加入丙酮或醇来实现。然后将沉淀物加到pH 8的1-抗坏血酸的磷酸盐或硼酸盐缓冲溶液中,将混合物在37-38℃下保温约20天。然后在不高于50℃的温度下用乙醚或氯仿萃取温育的物质,将含水残余物进行进一步温育,并将非水相与2.5%碳酸氢钠水溶液一起振摇两次。然后将非水相与0.5 N碳酸氢钠一起振摇,现在含有Splelin A的水相被硫酸酸化至pH 4.7。用氯仿萃取酸溶液,并用无水硫酸钠干燥萃取物,然后蒸发至干。将残余物用重石油醚吸收,将溶液与甲醇一起振摇,并将石油醚溶液蒸发至干。将残余物重新溶解在沸腾的丙酮中,并使丙酮达到室温,随后将脾蛋白A沉淀。通过少量半胱氨酸或氰化钠的存在来激活孵育步骤,并且在该步骤中,脱氢抗坏血酸,二酮葡糖酸和/或抗坏血酸的钠,钙或其他盐可以代替1-抗坏血酸使用。上文提到的碳酸氢盐处理之前的氯仿纯化步骤可以通过将Splenin A吸附​​在木炭上,然后用热甲醇处理以回收材料来代替。ALSO:通过减少动物体内出血时间而制成的制剂。从脾脏材料或大豆粉中提取的水提取物,从其中沉淀酶,将酶与具有维生素C活性的抗坏血酸物质一起温育,然后从溶液中回收产物。该产品命名为Splenin A,其经验式为C18H40O5或C18H36O5。酶从水提取物中的沉淀可以通过加入丙酮或醇来实现。然后可以将沉淀物加到pH 8的1-抗坏血酸在磷酸盐或硼酸盐缓冲溶液中的溶液中,将混合物在37-38℃下保温约20天。然后在不高于50℃的温度下用乙醚或氯仿萃取温育的物质,将含水残余物进行进一步温育,并将非水相与2.5%碳酸氢钠水溶液一起振摇两次。然后将非水相与0.5 N碳酸氢钠一起振摇,现在含有Splelin A的水相被硫酸酸化至pH 4.7。用氯仿萃取酸溶液,并用无水硫酸钠干燥萃取物,然后蒸发至干。将残余物用重石油醚吸收,将溶液与甲醇一起振摇,并将石油醚溶液蒸发至干。将残余物重新溶解在沸腾的丙酮中,并使丙酮达到室温,随后将脾蛋白A沉淀。通过少量半胱氨酸或氰化钠的存在来激活孵育步骤,并且在该步骤中,脱氢抗坏血酸,二酮葡糖酸和/或抗坏血酸的钠,钙或其他盐可以代替1-抗坏血酸使用。上文提到的碳酸氢盐处理之前的氯仿纯化步骤可以通过将Splenin A吸附​​在木炭上,然后用热甲醇处理以回收材料来代替。

著录项

  • 公开/公告号GB637309A

    专利类型

  • 公开/公告日1950-05-17

    原文格式PDF

  • 申请/专利权人 GEORGES UNGAR;

    申请/专利号GB19460012931

  • 发明设计人

    申请日1947-05-13

  • 分类号A61K35/28;

  • 国家 GB

  • 入库时间 2022-08-24 02:05:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号